Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0567 per EA under NDC 70710121005. Its NADAC has been published 407 times since Sep 12, 2018.
The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710121005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA210117On Market Since
2/8/2018
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 407 times since Sep 12, 2018, and over the history we have for it it has declined 62.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.1502 (Sep 12, 2018) |
| All-time low | $0.0552 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.0814 |
| Average price | $0.0867 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 407 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0567 per EA (NDC 70710121005), effective Jun 24, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 62.3%. It has been tracked across 407 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Sep 12, 2018, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.1502 (Sep 12, 2018), with a median of $0.0814 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as ALLOPURINOL 300 MG TABLET, but none are currently priced below it.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 70710121005) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification